In August, Scotiabank has closed the initial investment of approximately 4.9 percentage. "Our investment in KeyCorp represents a cost-effective, low-risk approach to deploying capital into the U.S.
BridgeBio Pharma Inc (BBIO) stock saw a modest uptick, ending the day at $28.53 which represents a slight increase of $0.76 or 2.74% from the prior close of $27.77. The stock opened at $27.76 and ...